J
Jeremy J. Erasmus
Researcher at Duke University
Publications - 110
Citations - 7077
Jeremy J. Erasmus is an academic researcher from Duke University. The author has contributed to research in topics: Lung cancer & Positron emission tomography. The author has an hindex of 37, co-authored 110 publications receiving 6514 citations. Previous affiliations of Jeremy J. Erasmus include University of Texas MD Anderson Cancer Center & University of Texas System.
Papers
More filters
Journal ArticleDOI
The BATTLE Trial: Personalizing Therapy for Lung Cancer
Edward S. Kim,Roy S. Herbst,Ignacio I. Wistuba,J. Jack Lee,George R. Blumenschein,Anne Tsao,David J. Stewart,Marshall E. Hicks,Jeremy J. Erasmus,Sanjay Gupta,Christine M. Alden,Suyu Liu,Ximing Tang,Fadlo R. Khuri,Hai T. Tran,Bruce E. Johnson,John V. Heymach,Li Mao,Frank V. Fossella,Merrill S. Kies,Vassiliki A. Papadimitrakopoulou,Suzanne E. Davis,Scott M. Lippman,Waun Ki Hong +23 more
TL;DR: The BATTLE study is the first completed prospective, adaptively randomized study in heavily pretreated NSCLC patients that mandated tumor profiling with "real-time" biopsies, taking a substantial step toward realizing personalized lung cancer therapy by integrating real-time molecular laboratory findings.
Journal ArticleDOI
Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions.
TL;DR: Evaluation of specific morphologic features of a solitary pulmonary nodule with conventional imaging techniques can help differentiate benign from malignant nodules and obviate further costly assessment.
Journal ArticleDOI
Pulmonary Drug Toxicity: Radiologic and Pathologic Manifestations
TL;DR: Pulmonary drug toxicity is increasingly being diagnosed as a cause of acute and chronic lung disease and knowledge of these manifestations and of the drugs most frequently involved can facilitate diagnosis and institution of appropriate treatment.
Journal ArticleDOI
Evaluation of primary pulmonary carcinoid tumors using FDG PET
TL;DR: On FDG PET imaging, pulmonary carcinoid tumors usually have lower FDG uptake than expected for malignant tumors, and biopsy or close radiologic follow-up is recommended for solitary pulmonary nodules that are clinically suspected of being carcinoid tumor and that do not show increased metabolic activity onFDG PET images.
Journal ArticleDOI
Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
Jeremy J. Erasmus,Edward F. Patz,H P McAdams,J G Murray,James E. Herndon,R E Coleman,Philip C. Goodman +6 more
TL;DR: PET with FDG is an accurate, noninvasive way to differentiate benign from metastatic adrenal masses in patients with bronchogenic carcinoma.